The SURMOUNT-1 trial [1] showed 22.5% weight [1] loss at 72 weeks with retatrutide 12mg, establishing its potency compared to single-receptor agonists
The FDA has not evaluated its safety, quality, or effectiveness for any health-related use
Bladder, bowel, sexual symptoms, I always think of endometriosis and then, of course, menstrual symptoms
By integrating targeted strength training and prioritizing protein intake, individuals can actively shape their weight loss journey to be not just about losing pounds, but about building a stronger, healthier, and more resilient body for the long term
Tirzepatide microdosing begins with subcutaneous injections at very low concentrationstypically starting at 1.25 to 2.5 micrograms per week
Ozempic (a brand name for the generic drug semaglutide ) belongs to a class of medications called GLP-1 receptor agonists